Not applicableStudy completedNCT07243899
What this trial is testing
Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy
Who this might be right for
NSCLC
Shanghai Zhongshan Hospital 3,000
Showing 2 of 2 results